Our first speaker is Dr. Kodsi.
Speaker:He's an Australian-trained adult medicine physician who qualifications in palliative
Speaker:medicine and pain medicine.
Speaker:He has a special interest in musculoskeletal and neuropathic pain,
Speaker:survivorship medicine, coordinating chronic and complex disease conditions,
Speaker:cancer pain, comorbidity of pain with addiction.
Speaker:Today, Dr. Kodsi will be speaking
Speaker:about Chronic pain, post-surgical pain management. Thanks, Dr. Kodsi.
Speaker:Let me start with a story, one that might be familiar to many of you in general practice.
Speaker:Margaret's a 62-year-old retired teacher who's always been independent,
Speaker:active and stoic when it comes to pain.
Speaker:Six months ago, she underwent a routine mastectomy for early stage breast cancer.
Speaker:The surgery was uneventful and her oncologist declared her cancer-free.
Speaker:But Margaret hasn't felt free. She tells you, her GP, I still have this burning,
Speaker:stabbing pain along the scar and into my armpit.
Speaker:I can't sleep on that site. I can't wear a bra.
Speaker:I can't even hug my grandchildren. It hurts.
Speaker:You've checked the site. It's clean. No signs of infection.
Speaker:Her surgeon says that the wound has healed. Her oncologist has moved on. But Margaret hasn't.
Speaker:This is chronic post-surgical pain. It affects about half of patients undergoing
Speaker:high risk procedures such as a mastectomy, thichotomy or an amputation.
Speaker:It still occurs with hip and or other orthopedic surgeons but much in a much
Speaker:less degree to about 15% and the most common place that it's diagnosed,
Speaker:it's not in the theatre or the ward, it's in your office.
Speaker:So today we'll be exploring chronic post-surgical pain and why it happens and
Speaker:more importantly how we can all have a role in trying to prevent it together.
Speaker:So hi everyone, I'm Anthony Kodsi, I'm a pain specialist and a palliative care
Speaker:physician, otherwise known as an unofficial human complaint sponge.
Speaker:I didn't always work in pain, I started general medicine, then I did palliative
Speaker:care, but somehow along the way I kept being called into situations where the
Speaker:patient was in pain and no one knew what to do next.
Speaker:Eventually I realised that's my job now.
Speaker:I often say that I meet patients when hope is waning thin and they've had the
Speaker:surgery, they've done the rehab, they've tried the medications and the pain's
Speaker:still no good. Or worse, it's even worse.
Speaker:I lead the pain department in Concord Hospital and I work across tertiary hospitals
Speaker:and I work alongside with the orthopedic surgeons here.
Speaker:And I work in both interventional pain and supportive care.
Speaker:My job is to step in when it starts to intrude on people's recovery or their life.
Speaker:But ideally, we don't wait for that moment. Ideally, we can collaborate early,
Speaker:before surgery, before opiate escalation, before the neural pathways lay down its tracks.
Speaker:That's why I'm here today, because you as GPs are not only the first port of
Speaker:call, you're the most consistent voice of patients here.
Speaker:And that puts you in a very powerful position to change their trajectory.
Speaker:Because the best chronic pain story is the one that never happens,
Speaker:the one that doesn't need to see me.
Speaker:So what do pain specialists do because I
Speaker:believe that sometimes there is
Speaker:a bit of misunderstanding or it's not
Speaker:well known what we do I do a lot of medication management counseling and deprescribing
Speaker:I help try to work out undifferentiated cases and some patients have had orthopedic
Speaker:surgery and they had quite a good success structurally and good range of motion
Speaker:but they still have persistent issues.
Speaker:So I try to assist alongside with the orthopedic surgeon in that scenario.
Speaker:I do diagnostic and therapeutic nerve blocks. I do some regenerative medicine
Speaker:work. We have the facilities.
Speaker:It's not always employed and there's a bit of difficult literature to go through
Speaker:to know which ones work best for which type of joints.
Speaker:Botox for refractory, spasticity and nerve pain and migraines particularly.
Speaker:Where you could see ablation pulse treatments and neuromodulation.
Speaker:And I work alongside you, the general practitioner and also the patient in a shared decision model.
Speaker:Most patients, the chronic pain that they have is not an indicator of harm and
Speaker:they should be able to mobilize and move.
Speaker:And a lot of patients have had incomplete rehabilitation after their surgery
Speaker:and they believe that pain had been a hindrance to that.
Speaker:So they all quite benefit from physical therapies, exercise or prescribed activity.
Speaker:And clinical psychologist because the burden of mental health problems with
Speaker:chronic pain patients is very severe and significant.
Speaker:So a bit of a history about chronic post-surgical pain.
Speaker:So a seminal paper by Sherman et al.
Speaker:40 years ago had a comprehensive mail questionnaire that was sent to 5,000 US
Speaker:military veterans with limb amputations.
Speaker:55% responded. This seminal survey showed a few findings.
Speaker:Phantom limb pain was very prevalent.
Speaker:About 78%, four-fifths of patients experienced phantom limb pain.
Speaker:Most of them had a lot of disability from this phantom limb pain.
Speaker:It didn't go away, no matter where it happened.
Speaker:And a lot of them had coexisting stump pain. In fact, it was very rare to have
Speaker:phantom limb pain without coexisting stump pain.
Speaker:And what was surprising, since I've only been a doctor for about 15 to 20 years,
Speaker:is that most of the treatments that they've all tried are very similar to what
Speaker:we have today, 40 years later.
Speaker:And only less than 1% reported lasting benefits from treatment.
Speaker:So this kind of shows a really high prevalence and functional impact of chronic
Speaker:post-surgical pain despite that the surgeons made sure that there's no other
Speaker:underlying structural issues are gone and they treated anything that they could see.
Speaker:Another seminal paper was a study 10 years later by Crombutyl and they had a
Speaker:survey of 5,000 patients.
Speaker:Sorry, this is too loud.
Speaker:Of 10 chronic pain clinics in Northern Britain.
Speaker:And they looked at the frequency of how many patients in the pain clinics were
Speaker:due to surgery or trauma.
Speaker:And they found about one-fifth of patients had surgery beforehand and is why
Speaker:they're in the pain clinic.
Speaker:So this is a very high prevalence of post-surgical pain issues.
Speaker:And most of them didn't have any other underlying pathology.
Speaker:The surgeons cleared them and they still had persistent pain.
Speaker:This also is a study that showed that the demographics between the surgery-related
Speaker:pain and those who had trauma-related pain were quite different and stark.
Speaker:So, 10 years later, before the ICD-11 and ICD-10 and other diagnostic manuals,
Speaker:they're starting to coin the word chronic post-surgical pain.
Speaker:And most of them try to reclassify them to other types of what surgeries they
Speaker:had because they had very different risk profiles.
Speaker:And arthroplasty also was seen as well.
Speaker:And most of it defines pain as that persists three months after the recurrence
Speaker:or persistence of the pain. So it has to stay for longer than three months to
Speaker:be considered chronic post-surgical pain.
Speaker:And it began or increased after surgery, usually in that very post-operative
Speaker:window or in a few months after the surgery.
Speaker:It's in the area of the surgery and it needs to be going on for three months.
Speaker:And they've excluded the most common causes, which is usually infection,
Speaker:the pre-existing condition, and the NCR and ER of alternative cause.
Speaker:The reason why this is different from acute pain is that acute pain is a physiological
Speaker:response to tissue injury.
Speaker:It is protective and it's usually time-limited.
Speaker:Chronic pain, on the other hand, involves neuroplastic changes that sustain
Speaker:pain long after tissue healing, and I'll be talking about that in a minute.
Speaker:The pain persists without ongoing noise-disceptive input, suggesting that there
Speaker:is central mechanisms of wind-up and loss of descending inhibitory control.
Speaker:So what happens? So interestingly, in the preoperative phase,
Speaker:people are set up to have failure and to have chronic pain.
Speaker:The odds ratio for certain demographic behaviours that are biologically not
Speaker:under anyone's control is being female, being younger sex, and having coexisting
Speaker:or chronic pain issues to start off with.
Speaker:Also psychological distress, being prone to catastrophic beliefs,
Speaker:Catastrophic beliefs have been probably the number one thing that's been now
Speaker:starting in the last 10 years Of trying to reduce that preoperatively to see
Speaker:if that improves and stops bad post-surgical outcomes,
Speaker:Unfortunately, most education and other interventions have not shown to really
Speaker:benefit or is either prohibitively too costly.
Speaker:The other thing that I'll talk about in a second is preoperative opioid use.
Speaker:And then after the postoperative period in our pain rounds, we look at these
Speaker:type of things, whether they had catastrophic beliefs there and we give them education.
Speaker:We look at also the other things. In the preoperative planning stage,
Speaker:I often talk to the anaesthetists about what their usual protocol or regime is,
Speaker:their regional blockade to try to reduce central sensitization and what kind
Speaker:of adjuvant analgesics can decrease wind-up pain.
Speaker:The surgical technique is also important.
Speaker:Preoperative opioids have been shown to have a very strong negative impact on a patient's recovery.
Speaker:It affects infection rates, readmission, prolonged stay,
Speaker:it causes higher costs and complications and longer hospital stays and they
Speaker:have worse pain and functional outcomes and it's not very clear that the opioid
Speaker:use just signifies that they have severe pain or a problem to start off with.
Speaker:It's really just the opioids.
Speaker:And tapering and multimodal strategies have been always suggested to try to reduce the risk.
Speaker:In fact, if you reduce the opioids by about 50% within two to three months before
Speaker:their operation, their risk is substantially decreased and they usually behave
Speaker:like the baseline population.
Speaker:The incidence per procedure is quite significant.
Speaker:And for our purposes today, amputation and hip arthroprasty and knee arthroprasty
Speaker:still have significant risks of chronic post-surgical pain.
Speaker:The surgical risk factors is not surprising at all.
Speaker:High tissue trauma surgeries have quite significant rates of chronic post-surgical pain.
Speaker:Nerve injury during surgery is another factor and adequate acute pain control.
Speaker:And surgical techniques, a study by Melko et al looked at prophylactic in the
Speaker:inner nerve excision during hernia repair.
Speaker:This is a famous study, and it found actually, interestingly,
Speaker:that if you excise the ingling nerve, there was less pain than just preserving
Speaker:the ingling nerve and it being under pressure by the mesh.
Speaker:So surgical techniques are always in every kind of field of surgery.
Speaker:There's always ongoing discussions about how best to reduce the risk of nerve
Speaker:injury and reduce chronic pain.
Speaker:So the reason for chronic pain involves both peripheral things that happen in
Speaker:the tissues and central sensitization.
Speaker:Peripheral injury causes a release of inflammatory mediators,
Speaker:particularly calcitonin receptor gene peptide, which lowers noisiceptive thresholds.
Speaker:It causes sensitization of the existing noisiceptive fibers.
Speaker:It causes more noisiceptive fibers. It causes collateral sprouting.
Speaker:It couples with the sympathetic overflow, which also lowers,
Speaker:again, the noisiceptive thresholds.
Speaker:And where nerve is cut, there is a nervi neborum.
Speaker:And central mechanisms also exist. Sensitization and other things that happen
Speaker:in the dorsal horn of the spine increases its more input and trafficking of
Speaker:noisiceptive signals and decreases dysinibutory control.
Speaker:So I'm going to talk about a controversial subject, but I'll talk about what we seem to know so far.
Speaker:We used to think preventative analgesia might be helpful, but there has been
Speaker:a lot of fortunate research in that department and less is known about where
Speaker:the place of preventative analgesia is.
Speaker:What is less controversial is the use of pre-emptive analgesia.
Speaker:So pre-emptive analgesia is treatment given prior to the incision.
Speaker:Pre-emptive analgesia is giving
Speaker:analgesia before and during and after the operation and the closure.
Speaker:The idea is this, that during surgery there's a lot of noise deceptive input
Speaker:and then there's less as the patient recovers from that first day and then they
Speaker:get another phase of increased noise deceptive input, more swelling,
Speaker:more inflammation, etc.
Speaker:And the hypersensitivity that occurs if you measure it also follows that noise deceptive input.
Speaker:If we just gave analgesia after the surgery, we might dampen that neurodeceptive
Speaker:input for a little bit, but that hypersensitivity doesn't really shift.
Speaker:If we gave pre-surgical analgesia, the idea is that they might not get much
Speaker:hypersensitivity from any inflammation, etc., that occurs in the operation,
Speaker:but they still will get hypersensitivity and that doesn't seem to improve outcomes
Speaker:for chronic post-surgical pain.
Speaker:The idea is that with pre-emptive analgesia,
Speaker:analgesia given throughout the trajectory for both in the operation and after
Speaker:closure that we can dampen or reduce or mitigate hypersensitivity.
Speaker:How do we measure hypersensitivity? One thing that we often do is look for alodynia
Speaker:by using a von Frey filament near the incision. So they're always quite tender.
Speaker:But using a filament that shouldn't cause pain or is not that noxious,
Speaker:if they feel allodyneed towards that, then they're likely very sensitized.
Speaker:So a study, a nice study was done
Speaker:by Levander-Home in 2005 looking at interoperative epidural analgesia.
Speaker:This was 85 patients with colonic cancer resected. They had two interventions.
Speaker:They all had epidural 30 minutes before incision and they had treatment between
Speaker:the incision and closure and then second are after skin closure.
Speaker:So all patients had a thoracic epidural catheter and both had IV and epidural infusions.
Speaker:Some of them though would have the study medication and the others would have saline.
Speaker:The consistent story is this.
Speaker:That if they had epidural buprenorphine, sorry,
Speaker:bubivacaine, and they had good analgesia postoperatively, their outcomes were very different.
Speaker:They had better postoperative pain, they were able to mobilize and cough,
Speaker:and this is surprising with epidurals because that caused hypertension and they
Speaker:might have less ability to mobilize because of just having the catheter.
Speaker:And they had decreased normally pain consistently.
Speaker:They were able to do other functional outcomes postoperatively.
Speaker:And the interesting thing is that they all had decreased hypersensitization.
Speaker:So when they were tested, they had much less sensitization in the epidural groups.
Speaker:And this had a translation effect months after the surgery.
Speaker:Those that received preemptive analgesia had decreased rates of chronic pain six or 12 months later.
Speaker:So in the orthopedic space, they don't often use epidural catheters.
Speaker:They often do regional analgesia and that has been shown to be just as good
Speaker:and might be safer than epidural catheters in reducing sensitization.
Speaker:The other techniques that we use, using gabapentinoids,
Speaker:etc., they had its place but it increases sedation risks and other problems
Speaker:in the postoperative periods and their benefit compared to their risks,
Speaker:haven't been shown to be something that we should be routinely using.
Speaker:In the post-operative phase, me as a pain specialist often tries to reduce their
Speaker:opioid use and look at their functional pain assessment outcomes rather than just the pain scores.
Speaker:And I also look for whether they have neuropathic pain because when they have neuropathic pain,
Speaker:they are more likely to benefit from a neuropathic agent to try to reduce their
Speaker:pain and reduce their opioid consumption as well.
Speaker:So I look for aledonia, I use the static and dynamic superficial techniques,
Speaker:I use a pin or I use a toothpick or a clip,
Speaker:I use a dynamic brush to see if there's a brush aledonia and I try to diagnose
Speaker:whether they have neuropathic pain as a reason for their high opioid use postoperatively.
Speaker:So opioids have a lot of risks that we'll discuss in the next slide.
Speaker:I often try to use non-steroidals as well with the surgeon's permission,
Speaker:particularly because it can affect healing.
Speaker:That's always a contentious issue of discussion.
Speaker:But a lot of surgeries have been shown that preoperatively even,
Speaker:that high doses of lexamethasone or COX-2 inhibitor like celicoxib can reduce
Speaker:their post-operative pain and outcomes.
Speaker:So this is worth discussing with your surgeon.
Speaker:Gabapentanoids, in some protocols,
Speaker:gabapentanoids have been shown to be helpful preoperatively to be used,
Speaker:such as with shoulder surgery, but they also have its own risk profile and in
Speaker:the elderly particularly,
Speaker:they're much less likely to tolerate it.
Speaker:Ketamine has its place but also not always well tolerated and IV lidocaine for short term as well.
Speaker:So, we have in the post-operative phase, we have a lot of options of opioids to use.
Speaker:Because today we're talking about the elderly, I have a few things to say.
Speaker:So fentanyl PCAs we often use because it's very short and it's more forgiving
Speaker:in renal failure, which is very common in the elderly.
Speaker:But it's not a great analgesic all the time because it has tachyphylaxis.
Speaker:So I don't know if anyone has tritrated a fentanyl patch before and gone to
Speaker:really high figures and not getting much pain relief.
Speaker:That's a property of fentanyl that doesn't seem to happen with other opioids.
Speaker:Another issue with fentanyl is because it has less euphoric effects.
Speaker:Some patients don't seem to get much benefit until we switch over to morphine or oxycodone.
Speaker:Morphine is very well tolerated still, but it has a more high incidence of nausea
Speaker:and histamine release compared to oxycodone.
Speaker:So oxycodone is preferred in many places.
Speaker:That said, very quickly we try to transition them from pure opioid agonists
Speaker:to pentadol or buprenorphine.
Speaker:And you might have noticed in the last five years that you're getting a lot
Speaker:of these post-op patients now on polexia and buprenorphine.
Speaker:But I'll say another thing. Tepentadol in the elderly has a higher risk of delirium.
Speaker:It also does seem to have a lowest seizure threshold, a bit more than other
Speaker:opioids and maybe a bit less than tramadol.
Speaker:It still has a bit of a small risk of increased constipation compared to the other things.
Speaker:And Tepentadol in Australia at least is not very titratable.
Speaker:In the United States, Tepentadol comes in as an oral syrup. It comes in 25 milligrams.
Speaker:We don't have these things, and that limits its use in the elderly.
Speaker:So in a few hospitals that I work with, terpentadol is not usually used for patients above 70 or 75.
Speaker:Buprenorphine, though, there is increased and increased data and more studies,
Speaker:particularly where I come from in Royal Prince Alfred, of using low doses of buprenorphine.
Speaker:It seems to be much more tolerated. Now the reason to talk about both dipentadol
Speaker:and buprenorphine and how this fits in opioid stewardship these days is these
Speaker:are both what's called atypical opioids.
Speaker:They are not pure opioid agonists and most of their mechanism for pain relief
Speaker:does not seem to be just their new opioid receptor agonist activity.
Speaker:It's more due to other mechanisms. That also decreases sensitization.
Speaker:And so therefore, it's not yet proven
Speaker:but there seems to be that if
Speaker:we shift to these other less drugs not
Speaker:only are patients less likely to misuse or
Speaker:abuse them in the post-operative period or continue to use them months and months
Speaker:later but it might have an impact in decreasing central sensitization in the
Speaker:post-operative period and thus decreasing the risk of chronic post-surgical pain.
Speaker:Another thing in the post-operative setting is
Speaker:that sometimes patients have increasing opioid use even in the community after
Speaker:they've been discharged and it's not explainable by believing that there might
Speaker:be a missed pathology or that the surgeons need to look again as to what is occurring.
Speaker:And that is diagnosed by a
Speaker:higher index of suspicion and the pain usually is very diffuse and poorly localized
Speaker:even beyond the surgical site and there's aladynia as I described on how to
Speaker:test and there's a lack of response when you escalate the opioid.
Speaker:So it could be neuropathic pain, that's the other differential and this usually
Speaker:occurs when the pure opioid agonists are used as well.
Speaker:So what do we do? I often try to rotate the opioid to try to mitigate the risks
Speaker:of the opioid-induced hyperalgesia.
Speaker:In the inpatient setting, I might use other treatments and in your setting,
Speaker:anti-inflammatories and gabapentinoids might be beneficial.
Speaker:So multimodal strategies are not only helpful in the intraoperative phase,
Speaker:it is still useful in the postoperative and in the community setting.
Speaker:And opioid sparing strategies like early rehabilitation is also important.
Speaker:So takeaways, post-surgical pain is persistent and recurrent pain lasting more
Speaker:than three months after surgery, after excluding other causes.
Speaker:The risk factors for chronic post-surgical pain is not just the surgery,
Speaker:it's also biological and demographic factors.
Speaker:And in particular, there are multiple factors, particularly still under your
Speaker:control, which is a preoperative opioid use and their psychological distress.
Speaker:The surgical impact has a key relationship with their chronic post-surgical risk history.
Speaker:There are preventative ways that both you and the anaesthetist,
Speaker:and pain specialist can employ in putting multimodal analgesic strategies even
Speaker:before incision and opioid management is important to mitigate the risks And
Speaker:if we look at the opioid and be stewards for them,
Speaker:we can also reduce possibly the chronic post-surgical pain history.
Speaker:Okay. So, thank you.